Access cutting-edge brain tumor treatment through this clinical trial at a research site in Indianapolis. Study-provided care at no cost to qualified participants.
Access brain tumor specialists in Indianapolis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related brain tumor treatment provided free
This phase II trial determines if the combination of ONC201 with different drugs, panobinostat or paxalisib, is effective for treating participants with diffuse midline gliomas (DMGs). Despite years of research, little to no progress has been made to improve outcomes for participants with DMGs, and there are few treatment options. ONC201, panobinostat, and paxalisib are all enzyme inhibitors that may stop the growth of tumor cells by clocking some of the enzymes needed for cell growth. This phas
Sponsor: University of California, San Francisco
Check if you qualify for this brain tumor clinical trial in Indianapolis, IN
If you're searching for brain tumor treatment options in Indianapolis, IN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Indianapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced brain tumor specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.